Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer
Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer
复制标题
RSPO融合阳性结直肠癌的临床病理和分子特征
DOI:
10.1038/s41416-022-01880-w
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Shiraishi K. and Sekine S.
中科院分区:
文献类型:
--
作者:
Hashimoto T.;Takayanagi D.;Yonemaru J.;Naka T.;Nagashima K.;Yatabe Y.;Shida D.;Hamamoto R.;Kleeman S. O.;Leedham S. J.;Maughan T.;Takashima A.;Shiraishi K. and Sekine S.
BackgroundRSPOfusions that lead to WNT pathway activation are potential therapeutic targets in colorectal cancer (CRC), but their clinicopathological significance remains unclear.MethodsWe screened 1019 CRCs forRSPOfusions using multiplex reverse transcription–PCR. TheRSPOfusion-positive tumours were subjected to whole-exome sequencing (WES).ResultsOur analysis identified 29 CRCs withRSPOfusions (2.8%), consisting of five with anEIF3E-RSPO2fusion and 24 withPTPRK-RSPO3fusions. The patients were 17 women and 12 men. Thirteen tumours (45%) were right-sided. Histologically, approximately half of the tumours (13/29, 45%) had a focal or extensive mucinous component that was significantly more frequent than theRSPOfusion-negative tumours (13%;P= 8.1 × 10−7). Four tumours (14%) were mismatch repair-deficient. WES identifiedKRAS,BRAF, andNRASmutations in a total of 27 tumours (93%). In contrast, pathogenic mutations in major WNT pathway genes, such asAPC,CTNNB1andRNF43, were absent.RSPOfusion status did not have a statistically significant influence on the overall or recurrence-free survival. These clinicopathological and genetic features were also confirmed in a pooled analysis of previous studies.ConclusionRSPOfusion-positive CRCs constitute a rare subgroup of CRCs with several characteristic clinicopathological and genetic features.
登录
查看更多内容
影响因子:
4.6
作者:
Fischer MM;Yeung VP;Cattaruzza F;Hussein R;Yen WC;Murriel C;Evans JW;O'Young G;Brunner AL;Wang M;Cain J;Cancilla B;Kapoun A;Hoey T
通讯作者:
Hoey T
影响因子:
3.5
作者:
Mizuguchi, Yasuhiko;Sakamoto, Taku;Sekine, Shigeki
通讯作者:
Sekine, Shigeki
影响因子:
2.2
作者:
Yonemaru Junpei;Hashimoto Taiki;Takayanagi Daisuke;Naka Tomoaki;Yatabe Yasushi;Kanemitsu Yukihide;Shiraishi Kouya;Sekine Shigeki
通讯作者:
Sekine Shigeki
影响因子:
5.2
作者:
Kleeman SO;Leedham SJ
通讯作者:
Leedham SJ
DOI:
--
发表时间:
--
期刊:
影响因子:
--
作者:
通讯作者:
--